{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:50:09Z","timestamp":1790787009768,"version":"4.1.0"},"reference-count":5,"publisher":"SAGE Publications","issue":"1S","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatitis"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1097\/der.0000000000000780","type":"journal-article","created":{"date-parts":[[2021,8,18]],"date-time":"2021-08-18T08:34:14Z","timestamp":1629275654000},"page":"e85-e86","source":"Crossref","is-referenced-by-count":38,"title":["Dual Efficacy of Upadacitinib in 2 Patients With Concomitant Severe Atopic Dermatitis and Alopecia Areata"],"prefix":"10.1177","volume":"32","author":[{"given":"Alessio","family":"Gambardella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Licata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"De Rosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Alfano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Argenziano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2021,9,2]]},"reference":[{"issue":"5","key":"bib1-20221027","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1016\/j.jaci.2018.06.029","article-title":"An integrated model of alopecia areata biomarkers highlights both TH1 and TH2 upregulation","volume":"142","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"bib2-20221027","first-page":"2020","article-title":"Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib","volume":"9","year":"2020","journal-title":"Drugs Context"},{"issue":"1","key":"bib3-20221027","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/09546634.2019.1577549","article-title":"JAK\/STAT inhibitors for the treatment of atopic dermatitis","volume":"31","year":"2020","journal-title":"J Dermatolog Treat"},{"issue":"2","key":"bib4-20221027","first-page":"e223","article-title":"Improvement of alopecia areata with dupilumab in a patient with severe atopic dermatitis and review the literature","volume":"61","year":"2020","journal-title":"Australas J Dermatol"},{"issue":"4","key":"bib5-20221027","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s13555-019-00329-y","article-title":"Scoping review on the use of drugs targeting JAK\/STAT pathway in atopic dermatitis, vitiligo, and alopecia areata","volume":"9","year":"2019","journal-title":"Dermatol Ther (Heidelb)"}],"container-title":["Dermatitis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/DER.0000000000000780","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T18:05:39Z","timestamp":1777399539000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.1097\/DER.0000000000000780"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,2]]},"references-count":5,"journal-issue":{"issue":"1S","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/der.0000000000000780","relation":{},"ISSN":["2162-5220","1710-3568"],"issn-type":[{"value":"2162-5220","type":"electronic"},{"value":"1710-3568","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9,2]]}}}